853:HKEXMicroPort Scientific Corp. Analysis
Data as of 2026-05-24 - not real-time
HK$0.17
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Vistar Holdings is trading near its recent resistance level while the 20‑day moving average sits below the market price, suggesting limited upside from a technical standpoint. The RSI is approaching the upper range and the MACD histogram has turned positive, creating a short‑term bullish signal, but the stock’s price remains well above the DCF‑derived fair value, indicating a material overvaluation.
Fundamentally the company reports thin gross and operating margins, a negative EBITDA, and negligible earnings per share, with cash modestly covering its debt load. High 30‑day volatility, a negative beta, and low liquidity further amplify risk, while the absence of any dividend underscores limited income appeal. Investors should weigh the bullish technical cues against weak financial health and an overvalued price before making a decision.
Fundamentally the company reports thin gross and operating margins, a negative EBITDA, and negligible earnings per share, with cash modestly covering its debt load. High 30‑day volatility, a negative beta, and low liquidity further amplify risk, while the absence of any dividend underscores limited income appeal. Investors should weigh the bullish technical cues against weak financial health and an overvalued price before making a decision.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price near resistance with limited upside
- technical overbought signals
- significant overvaluation relative to DCF
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- persistent thin margins and negative earnings
- high volatility and low liquidity
- lack of dividend and modest cash coverage of debt
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential for operational turnaround in engineering services
- stable regulatory environment for fire safety installations
- still overvalued but risk may moderate with market stabilization
Key Metrics & Analysis
Financial Health
Revenue Growth15.00%
Profit Margin0.14%
ROE0.26%
ROA0.10%
Debt/Equity25.08
P/B Ratio1.3
Op. Cash FlowHK$14.5M
Free Cash FlowHK$848.6K
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI63.9
SupportHK$0.12
ResistanceHK$0.17
MA 20HK$0.14
MA 50HK$0.16
MA 200HK$0.16
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair ValueHK$0.04
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.42
Volatility96.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.